Cover Image
市場調查報告書

大腸癌:全球臨床實驗檢討

Colon Cancer Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 146301
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
Back to Top
大腸癌:全球臨床實驗檢討 Colon Cancer Global Clinical Trials Review, H1, 2014
出版日期: 2014年03月12日 內容資訊: 英文 120 Pages
簡介

本報告提供全球主要地區的大腸癌症治療藥臨床實驗數和受驗人數,各階段趨勢,再加上主要企業和機關,臨床實驗簡介等。

簡介

  • 大腸癌
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區前五名國家的臨床實驗數量
    • 歐洲前五名國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量 大腸癌

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

參與大腸癌臨床實驗的主要企業

有潛力的藥劑

最新臨床實驗新聞 大腸癌

臨床實驗簡介

  • 主要企業臨床實驗概要
    • F. Hoffmann-La Roche Ltd.
    • Sanofi
    • Pfizer Inc.
    • Novartis AG
    • Amgen Inc.
    • GlaxoSmithKline plc
    • Immunomedics, Inc.
    • Eli Lilly and Company
    • AstraZeneca PLC
  • 代表性的研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • Memorial Sloan Kettering Cancer Center
    • The University of Texas M. D. Anderson Cancer Center
    • Stanford University
    • Barbara Ann Karmanos Cancer Institute
    • Mayo Clinic
    • Ohio State University Comprehensive Cancer Center
    • 昭和大學橫濱市北部醫院
    • Alberta Health Services
    • 大阪消化道癌化療研究會

5個代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2024CTIDB

GlobalData's clinical trial report, "Colon Cancer Global Clinical Trials Review, H1, 2014" provides data on the Colon Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Colon Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Colon Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Colon Cancer
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Colon Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Colon Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Colon Cancer
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Colon Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Colon Cancer
    • Oct 14, 2013: Reduced neurotoxicity with SPL's dendrimer enhanced oxaliplatin
    • Sep 11, 2013: Dendrimer-Oxaliplatin shows better anti-cancer efficacy and less toxicity
    • Jun 11, 2013: Novartis's AUY922 Shows Promise To Treat Breast And Lung Cancer In First-In-Human Phase I Trial
    • Jun 11, 2013: Critical Outcome Technologies Announces Positive Preclinical Results Of Cancer Drug Candidiate COTI-2 Against p53 Gene Mutations
    • May 20, 2013: PharmaMar Commences Phase Ib Trial With PM01183 In Combination With Capecitabine In Patients With Advanced Solid Tumors
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Immunomedics, Inc.
      • Clinical Trial Overview of Immunomedics, Inc.
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • The University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
      • Stanford University
      • Clinical Trial Overview of Stanford University
      • Barbara Ann Karmanos Cancer Institute
      • Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • Ohio State University Comprehensive Cancer Center
      • Clinical Trial Overview of Ohio State University Comprehensive Cancer Center
      • Showa University Northern Yokohama Hospital
      • Clinical Trial Overview of Showa University Northern Yokohama Hospital
      • Alberta Health Services
      • Clinical Trial Overview of Alberta Health Services
      • Osaka Gastrointestinal Cancer Chemotherapy Study Group
      • Clinical Trial Overview of Osaka Gastrointestinal Cancer Chemotherapy Study Group
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Colon Cancer Therapeutics, Global, Clinical Trials by Region, 2014*
  • Colon Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Colon Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Colon Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Colon Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Colon Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Colon Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Colon Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Colon Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Colon Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Colon Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Colon Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Colon Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Colon Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Colon Cancer Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Colon Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Colon Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Colon Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Colon Cancer Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Colon Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Colon Cancer Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Colon Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Colon Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Colon Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Colon Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Colon Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014*
  • Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Immunomedics, Inc., 2014*
  • Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
  • Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014*
  • Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014*
  • Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2014*
  • Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014*
  • Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University Comprehensive Cancer Center, 2014*
  • Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Showa University Northern Yokohama Hospital, 2014*
  • Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Alberta Health Services, 2014*
  • Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka Gastrointestinal Cancer Chemotherapy Study Group, 2014*

List of Figures

  • Colon Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Colon Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Colon Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Colon Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Colon Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Colon Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Colon Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Colon Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Colon Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Colon Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Colon Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Colon Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Colon Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Colon Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Colon Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Colon Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Colon Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Colon Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Colon Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Colon Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Colon Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Colon Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top